Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma; Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group; Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential; Denervation suppresses gastric tumorigenesis; Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling; Long-lived intestinal tuft cells serve as colon cancer–initiating cells; β2 adrenergic-neurotrophin feedforward loop promotes pancreatic cancer; Mist1 expressing gastric stem cells maintain the normal and neoplastic gastric epithelium and are supported by a perivascular stem cell niche; Projections of cancer incidence and cancer‐related deaths in Germany by 2020 and 2030; Dclk1 defines quiescent pancreatic progenitors that promote injury-induced regeneration and tumorigenesis; Krt19+/Lgr5− cells are radioresistant cancer-initiating stem cells in the colon and intestine; Cholinergic signaling via muscarinic receptors directly and indirectly suppresses pancreatic tumorigenesis and cancer stemness; Genetically engineered mouse models of pancreatic cancer; Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer; Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer; XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism; CCK2R identifies and regulates gastric antral stem cell states and carcinogenesis; Delivering precision oncology to patients with cancer; Neural innervation stimulates splenic TFF2 to arrest myeloid cell expansion and cancer; Intratumoral immunotherapy for early-stage solid tumors
